Literature DB >> 8988571

Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity.

A J Ruttenber1, J Lawler-Heavner, M Yin, C V Wetli, W L Hearn, D C Mash.   

Abstract

We describe an outbreak of deaths from cocaine-induced excited delirium (EDDs) in Dade County, Florida between 1979 and 1990. From a registry of all cocaine-related deaths in Dade County, Florida, from 1969-1990, 58 EDDs were compared with 125 victims of accidental cocaine overdose without excited delirium. Compared with controls, EDDs were more frequently black, male, and younger. They were less likely to have a low body mass index, and more likely to have died in police custody, to have received medical treatment immediately before death, to have survived for a longer period, to have developed hyperthermia, and to have died in summer months. EDDs had concentrations of cocaine and benzoylecgonine in autopsy blood that were similar to those for controls. The epidemiologic findings are most consistent with the hypothesis that chronic cocaine use disrupts dopaminergic function and, when coupled with recent cocaine use, may precipitate agitation, delirium, aberrant thermoregulation, rhabdomyolysis, and sudden death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988571

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  18 in total

Review 1.  Drug abusers who die during arrest or in custody.

Authors:  S B Karch; B G Stephens
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Cocaine: history, use, abuse.

Authors:  S B Karch
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

4.  Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates.

Authors:  Scott E Hemby; Wenxue Tang; Emil C Muly; Michael J Kuhar; Leonard Howell; Deborah C Mash
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

5.  Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.

Authors:  Deborah C Mash; Qinjie Ouyang; John Pablo; Margaret Basile; Sari Izenwasser; Abraham Lieberman; Richard J Perrin
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

6.  Disinhibiting neurons in the dorsomedial hypothalamus delays the onset of exertional fatigue and exhaustion in rats exercising in a warm environment.

Authors:  Dmitry V Zaretsky; Hannah Kline; Maria V Zaretskaia; Mary Beth Brown; Pamela J Durant; Nathan J Alves; Daniel E Rusyniak
Journal:  Brain Res       Date:  2018-03-22       Impact factor: 3.252

Review 7.  The syndrome of excited delirium.

Authors:  James R Gill
Journal:  Forensic Sci Med Pathol       Date:  2014-02-14       Impact factor: 2.007

8.  Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Authors:  Michael H Baumann; John S Partilla; Kurt R Lehner; Eric B Thorndike; Alexander F Hoffman; Marion Holy; Richard B Rothman; Steven R Goldberg; Carl R Lupica; Harald H Sitte; Simon D Brandt; Srihari R Tella; Nicholas V Cozzi; Charles W Schindler
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

9.  Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community.

Authors:  M S Pollanen; D A Chiasson; J T Cairns; J G Young
Journal:  CMAJ       Date:  1998-06-16       Impact factor: 8.262

10.  Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution.

Authors:  Xueying Jiang; Jian Zhou; Deborah C Mash; Ann M Marini; Robert H Lipsky
Journal:  Neuromolecular Med       Date:  2008-10-23       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.